Drug Type Biological products |
Synonyms dual S1P1/S1P5 agonists(LG Life Sciences Ltd.), dual sphingosine-1 phosphate receptor 1/sphingosine-1 phosphate receptor 5 agonists(LG Life Sciences Ltd.), LC-51-SPA |
Target |
Action agonists |
Mechanism S1PR1 agonists(Sphingosine 1-phosphate receptor Edg-1 agonists), S1PR5 agonists(Sphingosine 1-phosphate receptor Edg-8 agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Multiple Sclerosis | Discovery | South Korea | 01 Dec 2012 |